Fritextsökning
Innehållstyper
-
The FDA’s new transparency policy (Part 3)
As transparency and consistency become increasingly emphasized by the FDA, medical device manufacturers must approach their submissions with both thoroughness a...
-
Career coach on salaries: “There is no right or wrong”
What is a reasonable salary for my job? It's a question we all ask ourselves. But how important is a higher salary really? Career coach Tina Persson believes th...
-
Ranking: Top 10 highest-paid CEOs in pharma
It's nice to hear that things go well for others, right? Some of those who have done really well – at least financially – are listed here in the ranking of the best paid CEOs in Big Pharma 2023....
-
Trump in new push to lower drug prices
U.S. President Donald Trump announced on Sunday that he plans to sign an executive order to lower the cost of prescription drugs to the same levels paid in othe...
-
Introducing ZEISS arivis Pro 4.2
Your solution for advanced image analysis and visualization.
-
Anna Törner: ”Varför inte slå till på en ADHD-diagnos till kampanjpris?”
”Det är självklart positivt att neuropsykiatriska diagnoser inte upplevs som stigmatiserande, men just när det gäller ADHD kan jag inte låta bli att undra om de...
-
Introducing ZEISS arivis Pro 4.2
ZEISS arivis software enhances custom microscopy image analysis.
-
Who pays for Rebecca Doe – and all of us?
Anna Törner on how easily we get used to the idea that healthcare is free - when it really is about how and who pays for it
-
Roche’s Genentech terminates licencing deal with Norwegian biotech
Genentech is ending a license collaboration with Norwegian biotech Nykode Therapeutics regarding a clinical stage cancer vaccine program.
-
US Health Secretary Kennedy dismisses all vaccine experts – assembles new committee
Robert F. Kennedy Jr. has dismissed all 17 members of the CDC’s vaccine advisory panel. A new group of experts will be appointed directly by the Health Secretar...
-
Grönt ljus för Kennedy sänker läkemedelsbolag
Flera läkemedelsbolag backar på börsen efter att senatskommittén godkänt Robert F. Kennedy Jr som kandidat till landets hälsominister.
-
Investment CEO: “The Nordics are outstanding in creating successful medtech companies”
Since the beginning of last month, Susanna Francke Rodau has been a partner and the new CEO of Segulah Medical Acceleration, which invests in medical technology...
-
Improve Productivity and Accessibility with Award-winning Human-Centered Design
Enhance your workflow with integrated intelligence.
-
Automate E2E Image Analysis Pipelines
ZEISS arivis Pro - Your End-to-End Scientific Image Analysis Software.
-
Wilden för pulveröverföring
Wilden® tryckluftsdrivna membranpump för pulveröverföring. Säker, pålitlig och effektiv
-
60% energibesparing med Wilden Pro-Flo Shift
Systemet är till och med 25–30% effektivare än de senaste och mest effektiva luftbesparingssystemen som finns på marknaden idag!
-
Larm: Varningsnätverk för globala sjukdomsutbrott kan kollapsa
Varningssystemet för sjukdomsutbrott, Pro Med, som bland annat var en av de första att varna världen om covid-19 tycks vara nära kollaps.
-
Tidigare Tobii-chef blir vd för Surgical Science
Tom Englund, tidigare toppnamn inom Tobii-koncernen, är nuvarande operativ chef för Instabee. Nu lämnar han budbolaget och återvänder till medicinteknikfältet n...
-
60% energibesparing med Wilden Pro-Flo Shift
Wildens unika och patenterade luftsystem Pro-Flo Shift® ger upp till 60% besparing av drivluft.
-
Automated dispensing of a viscous hydrogel
A suitable solution developed for UPM Biomedicals In the Festo LifeTech Application Center we tested a setup for UPM Biomedicals for the automatic dispensing of...
-
Faster development of reliable sample handling
Festo USA has collaborated with PerkinElmer to develop a compact sample handling solution for a global leader in manufacturing medical devices. Thanks to the cu...
-
Anna Törner: The minute between life and death
“I have never told anyone about this day that happened more than 20 years ago. But I sometimes reflect on what happened, on what might have happened. When I try...
-
Innovative start-up helps doctors, scientists and industry balance coagulation risks
For many doctors caring for seriously ill patients, for example, in stroke units and cancer wards, maintaining the life-saving balance between bleeding and thro...
-
Oasmia tar in 151 miljoner – och byter namn
Styrelsen i cancerforskningsföretaget Oasmia har beslutat om en nyemission på 151 miljoner kronor. Samtidigt föreslås ett namnbyte av företaget till Vivesto.
BREAKING